192 related articles for article (PubMed ID: 23498306)
1. A 6-week randomized controlled trial with 4-week follow-up of acupuncture combined with paroxetine in patients with major depressive disorder.
Qu SS; Huang Y; Zhang ZJ; Chen JQ; Lin RY; Wang CQ; Li GL; Wong HK; Zhao CH; Pan JY; Guo SC; Zhang YC
J Psychiatr Res; 2013 Jun; 47(6):726-32. PubMed ID: 23498306
[TBL] [Abstract][Full Text] [Related]
2. Manual or electroacupuncture as an add-on therapy to SSRIs for depression: A randomized controlled trial.
Zhao B; Li Z; Wang Y; Ma X; Wang X; Wang X; Liu J; Huang Y; Zhang J; Li L; Hu X; Jiang J; Qu S; Chai Q; Song M; Yang X; Bao T; Fei Y
J Psychiatr Res; 2019 Jul; 114():24-33. PubMed ID: 31015098
[TBL] [Abstract][Full Text] [Related]
3. Can acupuncture combined with SSRIs improve clinical symptoms and quality of life in patients with depression? Secondary outcomes of a pragmatic randomized controlled trial.
Zhao B; Li Z; Wang Y; Ma X; Wang X; Wang X; Liang Y; Yang X; Sun Y; Song M; Guo T; Bao T; Fei Y
Complement Ther Med; 2019 Aug; 45():295-302. PubMed ID: 31331577
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
Trivedi MH; Pigotti TA; Perera P; Dillingham KE; Carfagno ML; Pitts CD
J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of controlled-release paroxetine in the treatment of late-life depression.
Rapaport MH; Schneider LS; Dunner DL; Davies JT; Pitts CD
J Clin Psychiatry; 2003 Sep; 64(9):1065-74. PubMed ID: 14628982
[TBL] [Abstract][Full Text] [Related]
7. Factor analysis of electroacupuncture and selective serotonin reuptake inhibitors for major depressive disorder: an 8-week controlled clinical trial.
Yang X; Gong W; Ma X; Wang S; Wang X; Guo T; Guo Z; Sun Y; Li J; Zhao B; Tu Y
Acupunct Med; 2020 Feb; 38(1):45-52. PubMed ID: 31544488
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of mirtazapine as add-on to paroxetine
Xiao L; Zhu X; Gillespie A; Feng Y; Zhou J; Chen X; Gao Y; Wang X; Ma X; Gao C; Xie Y; Pan X; Bai Y; Xu X; Wang G; Chen R
Psychol Med; 2021 May; 51(7):1166-1174. PubMed ID: 31931894
[TBL] [Abstract][Full Text] [Related]
9. Personality change during depression treatment: a placebo-controlled trial.
Tang TZ; DeRubeis RJ; Hollon SD; Amsterdam J; Shelton R; Schalet B
Arch Gen Psychiatry; 2009 Dec; 66(12):1322-30. PubMed ID: 19996037
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
Yu YM; Gao KR; Yu H; Shen YF; Li HF
J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.
Baldwin DS; Cooper JA; Huusom AK; Hindmarch I
Int Clin Psychopharmacol; 2006 May; 21(3):159-69. PubMed ID: 16528138
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Cui X; Calabrese JR; Gao K;
J Clin Psychopharmacol; 2011 Oct; 31(5):638-42. PubMed ID: 21869688
[TBL] [Abstract][Full Text] [Related]
13. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.
Preskorn SH; Baker B; Kolluri S; Menniti FS; Krams M; Landen JW
J Clin Psychopharmacol; 2008 Dec; 28(6):631-7. PubMed ID: 19011431
[TBL] [Abstract][Full Text] [Related]
14. Additional value of auricular intradermal acupuncture alongside selective serotonin reuptake inhibitors: a single-blinded, randomized, sham-controlled preliminary clinical study.
Wang H; Liu XR; Wu XJ; He TZ; Miao D; Jiang JF; Qiao HF; Yeung WF; Sun ZL
Acupunct Med; 2021 Dec; 39(6):596-602. PubMed ID: 33657871
[TBL] [Abstract][Full Text] [Related]
15. Addition of an NK1 receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorder.
Ball WA; Snavely DB; Hargreaves RJ; Szegedi A; Lines C; Reines SA
Hum Psychopharmacol; 2014 Nov; 29(6):568-77. PubMed ID: 25330122
[TBL] [Abstract][Full Text] [Related]
16. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
Perry EB; Berman RM; Sanacora G; Anand A; Lynch-Colonese K; Charney DS
J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Perahia DG; Wang F; Mallinckrodt CH; Walker DJ; Detke MJ
Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
[TBL] [Abstract][Full Text] [Related]
18. Clinical observation on treatment of depression by electro-acupuncture combined with Paroxetine.
Zhang GJ; Shi ZY; Liu S; Gong SH; Liu JQ; Liu JS
Chin J Integr Med; 2007 Sep; 13(3):228-30. PubMed ID: 17898957
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine controlled-release formulation in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled study in Japan and Korea.
Higuchi T; Hong JP; Jung HY; Watanabe Y; Kunitomi T; Kamijima K
Psychiatry Clin Neurosci; 2011 Dec; 65(7):655-63. PubMed ID: 21895859
[TBL] [Abstract][Full Text] [Related]
20. [Anti-depressive effect of acupuncture on selective serotonin reuptake inhibitors].
Huang Y; Wang XJ; Wang LL; Lu SF; Zhu BM; Xu LF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1341-4. PubMed ID: 24432676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
